If you look at the SP from a charting POV, then it is way oversold and IMHO a correction to the upside is imminent. However, it is possible that the approval and more importantly first sales are some way off yet as indicated by the RBS report in January. They have modelled first sales as 4QFY10 which could be part of the reason for the depressed SP.
Cheers,
- Forums
- ASX - By Stock
- getting carted
If you look at the SP from a charting POV, then it is way...
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
Previous Video
Next Video
SPONSORED BY The Market Online